Free Trial
NASDAQ:MESO

Mesoblast (MESO) Stock Price, News & Analysis

Mesoblast logo
$10.79 -0.07 (-0.64%)
Closing price 07/3/2025 03:26 PM Eastern
Extended Trading
$10.79 0.00 (0.00%)
As of 07/3/2025 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mesoblast Stock (NASDAQ:MESO)

Key Stats

Today's Range
$10.56
$10.82
50-Day Range
$10.16
$12.71
52-Week Range
$5.78
$22.00
Volume
208,906 shs
Average Volume
277,456 shs
Market Capitalization
$1.38 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Mesoblast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

MESO MarketRank™: 

Mesoblast scored higher than 47% of companies evaluated by MarketBeat, and ranked 564th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesoblast has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Mesoblast has received no research coverage in the past 90 days.

  • Read more about Mesoblast's stock forecast and price target.
  • Earnings Growth

    Earnings for Mesoblast are expected to grow in the coming year, from ($0.70) to ($0.32) per share.

  • Price to Book Value per Share Ratio

    Mesoblast has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Mesoblast's valuation and earnings.
  • Percentage of Shares Shorted

    2.59% of the float of Mesoblast has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently increased by 3.07%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Mesoblast does not currently pay a dividend.

  • Dividend Growth

    Mesoblast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.59% of the float of Mesoblast has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently increased by 3.07%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Mesoblast has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Mesoblast this week, compared to 4 articles on an average week.
  • Search Interest

    2 people have searched for MESO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Mesoblast to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesoblast insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.80% of the stock of Mesoblast is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 1.43% of the stock of Mesoblast is held by institutions.

  • Read more about Mesoblast's insider trading history.
Receive MESO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

MESO Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Mesoblast Limited (MSB.AX)
See More Headlines

MESO Stock Analysis - Frequently Asked Questions

Mesoblast's stock was trading at $19.80 at the beginning of 2025. Since then, MESO shares have decreased by 45.5% and is now trading at $10.79.

Mesoblast Limited (NASDAQ:MESO) posted its earnings results on Wednesday, August, 30th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.34) by $0.06. The business had revenue of $2.14 million for the quarter, compared to analysts' expectations of $2 million.
Read the conference call transcript
.

Mesoblast's stock reverse split on the morning of Friday, January 5th 2024.The 1-2 reverse split was announced on Friday, January 5th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, January 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 50 shares after the split.

Mesoblast (MESO) raised $69 million in an IPO on Friday, November 13th 2015. The company issued 5,700,000 shares at $12.10 per share. J.P. Morgan and Credit Suisse served as the underwriters for the IPO and Maxim Group and Ladenburg Thalmann were co-managers.

Shares of MESO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesoblast investors own include NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), Meta Platforms (META), CRISPR Therapeutics (CRSP) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
8/30/2023
Today
7/06/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MESO
Previous Symbol
OTCMKTS:MBLTY
Employees
80
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.00
High Stock Price Target
$24.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+66.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.67 million
Price / Cash Flow
N/A
Book Value
$4.21 per share
Price / Book
2.56

Miscellaneous

Free Float
103,756,000
Market Cap
$1.38 billion
Optionable
Optionable
Beta
2.39

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MESO) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners